Charles River Laboratories International (CRL) Change in Account Payables (2009 - 2025)

Charles River Laboratories International's Change in Account Payables history runs 17 years deep, the most recent figure standing at -$37.9 million for Q4 2025.

• In Q4 2025, Change in Account Payables fell 427.84% year-over-year to -$37.9 million; the TTM figure through Dec 2025 stood at $2.9 million (up 120.1% YoY), while the FY2025 annual figure was $2.9 million, up 120.1% from the prior year.
• Change in Account Payables for Q4 2025 stood at -$37.9 million, down from $24.5 million in the prior quarter.
• The five-year high for Change in Account Payables was $40.9 million in Q1 2022, with the low at -$41.3 million in Q2 2023.
• The 5-year median for Change in Account Payables is -$1.1 million (2023), against an average of $521000.0.
• Peak annual rise in Change in Account Payables reached 3818.66% in 2025, while the deepest fall reached 528.03% in 2025.
• Charles River Laboratories International's Change in Account Payables stood at $33.5 million in 2021, then tumbled by 125.79% to -$8.6 million in 2022, then jumped by 170.72% to $6.1 million in 2023, then plunged by 217.56% to -$7.2 million in 2024, then plunged by 427.84% to -$37.9 million in 2025.
• Business Quant data shows CRL's Change in Account Payables at -$37.9 million in Q4 2025, $24.5 million in Q3 2025, and -$9.0 million in Q2 2025.